Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHA | KEEL |
|---|---|---|
| Price | $11.19 | $3.45 |
| Change today | ▲ 1.91% | ▼ 4.70% |
| Market cap | $2.13B | $2.13B |
| Return, 3 months | +0.9% | -22.3% |
| Return, year to date | -3.8% | +46.8% |
| Return, 1 year | -28.7% | -0.3% |
| P/E (TTM) | 10.7 | -4.6 |
| P/B | 1.7 | 6.5 |
| P/E percentile vs own 5y | 65th | 36th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +4.0% | – |
| Net profit growth (YoY) | -52.8% | – |
| Gross margin | 45.8% | – |
| Operating margin | 10.4% | – |
| Net margin | 9.2% | – |
| Return on equity | – | – |
| Analyst target vs. price | +44.3% | +85.5% |
| Analyst buy share | 100% | 83% |
| RSI (14) | 45 | 45 |
| 30-day volatility | 47.6% | 77.8% |
| Max drawdown, 1 year | -44.3% | -73.6% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
